Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p8)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

211-260 of about 500 reports
Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022

Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Firmagon (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022

Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Jevtana (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022

Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Provenge (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022

Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zytiga (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022

Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Xtandi (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, United States, Canada, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022

Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022

Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zometa (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022

Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Cabozantinib (Prostate Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : World, Canada, Spain, Italy, France, Germany, Japan, United States, Australia, Europe, United Kingdom
Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022

Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Custirsen Sodium (Prostate Cancer) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022

Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Sprycel (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022

Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Yervoy (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022

Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Orteronel (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022

Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zoladex (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022

Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Alpharadin (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022

Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Lupron Depot (Prostate Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Australia, World, Canada, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Oceania
Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022

Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Tasquinimod (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Caldera Health Limited - Product Pipeline Analysis

Caldera Health Limited - Product Pipeline Analysis

  • $ 750
  • Company report
  • December 2012
  • by Global Data

Summary Caldera Health Limited (Caldera) develops diagnostic devices for the detection of early stage prostate cancer. Its portducts include ProscaNZ, a blood test for prostate cancer, that extends the ...

  • Industries : Pathology
  • Countries : New Zealand
Biosceptre International Limited - Product Pipeline Analysis

Biosceptre International Limited - Product Pipeline Analysis

  • $ 750
  • Company report
  • December 2012
  • by Global Data

Summary Biosceptre International Limited (Biosceptre) is a biotechnology company. It develops and commercializes antibody materials for the diagnosis and treatment of cancer. The company offers a broad ...

  • Industries : Pathology
  • Countries : Australia, United States
FBE Pty Ltd - Product Pipeline Analysis

FBE Pty Ltd - Product Pipeline Analysis

  • $ 750
  • Company report
  • December 2012
  • by Global Data

Summary FBE Pty Ltd (FBE) is a biomedical engineering consultancy firm. The company was formed by Flinders Medical Center Foundation (FMCF). FBE provides biomedical engineering consultancy, and medical ...

  • Industries : Drug Discovery and Development
  • Countries : Australia
Hepatorenal Syndrome - Pipeline Review, H2 2012

Hepatorenal Syndrome - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Hepatorenal Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Hepatorenal Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World, United States, Australia
Vitamins & Minerals - Australia (2012)

Vitamins & Minerals - Australia (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

Vitamins & Minerals in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
Orphan Drugs: Market Environment Products and Companies

Orphan Drugs: Market Environment Products and Companies

  • $ 1 566
  • Industry report
  • December 2012
  • by Espicom Business Intelligence

The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Japan, Sweden
OTC Medications - Australia (2012)

OTC Medications - Australia (2012)

  • $ 599
  • Industry report
  • December 2012
  • by Mintel

OTC Medications in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...

  • Industries : Over-the-counter Drug
  • Countries : Australia
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update Summary GlobalData has released its new Country report, ?PharmaPoint: Rheumatoid Arthritis - Australia ...

  • Industries : Pathology
  • Countries : Australia
Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Spain, Italy, France, Germany, Japan, World, United States, Europe, United Kingdom
Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Japan, Australia, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, Czech Republic, United States, Spain, Italy, France, Germany, Japan, World, Europe, United Kingdom
Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, India
Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis. ...

  • Industries : Pathology
  • Countries : United States, Spain, Italy, France, Germany, World, Australia, Europe, United Kingdom
Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis. The ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, India, China, United States, Europe, United Kingdom

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.